cefoperazone has been researched along with Bleeding in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gu, C; Lin, C; Tan, M; Wang, D; Wang, S; Wu, Y | 1 |
Dong, D; Li, J; Li, S; Liu, Y; Su, N; Sun, X; Tan, J; Wang, W; Wu, G; Wu, Y; Xiong, W; Yu, C; Zhang, R; Zong, Z; Zou, K | 1 |
Inamatsu, T; Matsuda, T; Shimada, K; Urayama, K | 1 |
Green, D; Mueller, RJ; Phair, JP | 1 |
4 other study(ies) available for cefoperazone and Bleeding
Article | Year |
---|---|
Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.
Topics: Afibrinogenemia; Anti-Bacterial Agents; Cefoperazone; Fibrinogen; Fibrinolytic Agents; Hemoglobins; Hemorrhage; Humans; Retrospective Studies; Sulbactam; Tigecycline | 2023 |
Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Blood Coagulation Disorders; Blood Platelets; Cefoperazone; Ceftazidime; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Prothrombin Time; Sulbactam; Tazobactam; Young Adult | 2020 |
Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics.
Topics: Aged; Bacteria; Blood Coagulation Factors; Cefazolin; Cefmetazole; Cefoperazone; Ceftazidime; Cephalosporins; Cephamycins; Female; Hemorrhage; Humans; Injections, Intravenous; Intestines; Male; Moxalactam; Vitamin K; Vitamin K Deficiency | 1984 |
Hypoprothrombinemia associated with cefoperazone therapy.
Topics: Aged; Cefoperazone; Costs and Cost Analysis; Hemorrhage; Humans; Hypoprothrombinemias; Middle Aged; Prothrombin Time; Retrospective Studies; Time Factors; Vitamin K 1 | 1987 |